“…Furthermore, the results of the LEfSe analysis in female and male 3xTg-AD mice at 3 and 5 months old in fecal samples, show bacteria with a statistically significant change in LDA scores such as Xanthomonadaceae , Oxalobacteraceae , Streptomycetaceae , Koribacteraceae , and Streptomycetaceae families, Gemella , Dehalobacterium , Clostridium , Allobaculum , Selenomonas , Veillonella , Lactococcus , Desulfovibrio , Bradyrhizobium , Campylobacter , Erythrobacter , Neisseria , Flexispira , Microbacterium , Collinsella , Atopobium , Pedobacter , and the S1 genera. These microorganisms have been associated with both pre-clinical models and patients who present AD mainly; however, other bacteria are related to aging, cognitive decline, cerebral damage, and inflammatory response in mice and humans ( Thomas et al, 2012 ; Wang et al, 2016 ; Bonfili et al, 2017 ; Harach et al, 2017 ; Morris et al, 2017 ; Vogt et al, 2017 ; Zhang et al, 2017 ; Aguayo et al, 2018 ; Alonso et al, 2018 ; Antonets et al, 2018 ; Bäuerl et al, 2018 ; Dong et al, 2018 ; Zhuang et al, 2018 ; Haran et al, 2019 ; Li et al, 2019 ; Zhan et al, 2019 ; Beydoun et al, 2020 ; Na et al, 2020 ; Westfall et al, 2020 ). These results suggest that bacteria families and genera are representative microorganisms of gut microbiota of disease that could be considered a useful tool for diagnostic as well as a progression biomarker of AD.…”